Durables responses with anti‐CD19 allogeneic CAR T ALLO‐501/501A in phase 1 trials of relapsed/refractory large B‐cell lymphoma (R/R LBCL) Meeting Abstract
| Authors: | Locke, F. L.; Lekakis, L.; Eradat, H.; Munoz, J.; Tees, M.; de Vos, S.; Nath, R.; Stevens, D.; Malik, S.; Popplewell, L.; Hamadani, M.; Oluwole, O.; Perales, M.; Miklos, D.; Fisher, P.; Goyal, L.; Navale, L.; Kaufman, G.; Kai, K.; Balakumaran, A.; Neelapu, S. |
| Abstract Title: | Durables responses with anti‐CD19 allogeneic CAR T ALLO‐501/501A in phase 1 trials of relapsed/refractory large B‐cell lymphoma (R/R LBCL) |
| Meeting Title: | 17th International Conference on Malignant Lymphoma (ICML) |
| Journal Title: | Hematological Oncology |
| Volume: | 41 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Jun 13-17 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2023-06-01 |
| Start Page: | 85 |
| End Page: | 86 |
| Language: | English |
| DOI: | 10.1002/hon.3163_48 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting Abstract: 048 -- Source: Cinahl |
